GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced
September 06, 2023 08:00 ET
|
GeneDx Holdings Corp.
STAMFORD, Conn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today announced a monumental accomplishment in its...
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
August 07, 2023 08:00 ET
|
GeneDx Holdings Corp.; PacBio
MENLO PARK, Calif. and STAMFORD, Conn., Aug. 07, 2023 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions and GeneDx (Nasdaq: WGS), a...
GeneDx Announces New Tool to Help Harness Human Pangenome Diversity for Clinical Interpretation of Variants
June 26, 2023 16:01 ET
|
GeneDx Holdings Corp.
New paper published today in Nature Methods describes the PanGenome Research-Tool Kit for analyzing complex regions of the human pangenome Recently released human pangenome better represents...
GeneDx to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
April 18, 2023 16:05 ET
|
GeneDx Holdings Corp.
STAMFORD, Conn., April 18, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced it will release...
GeneDx Appoints Devin K. Schaffer, J.D., M.B.A, as General Counsel
April 03, 2023 08:30 ET
|
GeneDx Holdings Corp.
STAMFORD, Conn., April 03, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that Devin K....
GeneDx honors Rare Disease Day and announces presentations and research at the 2023 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
February 28, 2023 08:30 ET
|
GeneDx Holdings Corp.
STAMFORD, Conn., Feb. 28, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced its contributions to...
PacBio Collaborates with iLAC and Robotic Biology Institute to Develop Automated Workflows
May 08, 2022 19:00 ET
|
PacBio
MENLO PARK, Calif., TOKYO, May 09, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with...
パックバイオ (PacBio)、iLACおよびロボティック･バイオロジー･インスティテュート株式会社 (Robotic Biology Institute) と共同で自動化ワークフローを開発
May 08, 2022 19:00 ET
|
Pacific Biosciences of California, Inc.
カリフォルニア州メンローパークおよび東京発, May 09, 2022 (GLOBE NEWSWIRE) -- 高品質･高精度のシーケンシングソリューションのリーディングカンパニーであるパックバイオ (PacBio) (NASDAQ: PACB) は、ゲノム解析企業である株式会社アイラック (iLAC, Inc.)、およびロボティック･バイオロジー･インスティテュート株式会社 (Robotic...
PacBio Supports SickKids to Investigate Use of HiFi Sequencing in Undiagnosed Genetic Conditions
February 28, 2022 09:00 ET
|
PacBio
MENLO PARK, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- PacBio, a leading provider of high-quality, highly accurate sequencing platforms, today announced it will be supporting The Hospital for Sick...
PacBio Welcomes Dr. Michael Eberle as Vice President of Computational Biology
February 23, 2022 09:00 ET
|
PacBio
MENLO PARK, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, welcomes Michael Eberle, Ph.D., as Vice...